Cross-talk between the p42/p44 MAP kinase and Smad pathways in transforming growth factor β1-induced furin gene transactivation

被引:104
|
作者
Blanchette, F
Rivard, N
Rudd, P
Grondin, F
Attisano, L
Dubois, CM [1 ]
机构
[1] Univ Sherbrooke, Fac Med, Div Immunol, Sherbrooke, PQ J1H 5N4, Canada
[2] Univ Sherbrooke, Fac Med, Dept Anat & Biol Cellulaire, Sherbrooke, PQ J1H 5N4, Canada
[3] Univ Toronto, Dept Anat & Cell Biol, Toronto, ON M5S 1A8, Canada
关键词
D O I
10.1074/jbc.M100093200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Furin, a predominant convertase of the cellular constitutive secretory pathway, is known to be involved in the maturation of a number of growth/differentiation factors, but the mechanisms governing its expression remain elusive. We have previously demonstrated that transforming growth factor (TGF) beta1, through the activation of Smad transducers, regulates its own converting enzyme, furin, creating a unique activation/regulation loop of potential importance in a variety of cell fate and functions. Here we studied the involvement of the p42/p44 MAPK pathway in such regulation. Using HepG2 cells transfected with fur P1 LUC (luciferase) promoter construct, we observed that forced expression of a dominant negative mutant form of the small G protein p21(ras) (RasN17) inhibited TGF beta1-induced far gene transcription, suggesting the involvement of the p42/p44 MAPK cascade. In addition, TGF beta induced sustained activation/phosphorylation of endogenous p42/p44 MAPK. Further-more, the role of MAPK cascade in far gene transcription was highlighted by the use of the MEK1/2 inhibitors, PD98059 or U0126, or co-expression of a p44 antisense construct that repressed the induction of fur promoter transactivation. Conversely, overexpression of a constitutively active form of MEK1 increased unstimulated, TGF beta1-stimulated, and Smad2-stimulated promoter P1 transactivation, and the universal Smad inhibitor, Smad7, inhibited this effect. Activation of Smad2 by MEK1 or TGF beta1 resulted in an enhanced nuclear localization of Smad2, which was inhibited upon blocking MEK1 activity. Our findings clearly show that the activation of the p42/p44 MAPK pathway is involved in far gene expression and led us to propose a co-operative model whereby TGF beta1-induced receptor activation stimulates not only a Smad pathway but also a parallel p42/p44 MAPK pathway that targets Smad2 for an increased nuclear translocation and enhanced fur gene transactivation. Such an uncovered mechanism may be a key determinant for the regulation of furin in embryogenesis and growth-related physiopathological conditions.
引用
收藏
页码:33986 / 33994
页数:9
相关论文
共 50 条
  • [1] Growth factor activated p42/p44 MAP kinases:: Mechanism of nuclear translocation
    Lenormand, P
    Bossis, G
    Brunet, A
    Brondello, JM
    Grall, D
    McKenzie, F
    Pagès, G
    Roux, D
    Pouysségur, J
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (04) : R784 - R784
  • [2] The p42/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal
    Le Gall, M
    Chambard, JC
    Breittmayer, JP
    Grall, D
    Pouysségur, J
    van Obberghen-Schilling, E
    MOLECULAR BIOLOGY OF THE CELL, 2000, 11 (03) : 1103 - 1112
  • [3] p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts
    Milanini, J
    Viñals, F
    Pouysségur, J
    Pagès, G
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (29) : 18165 - 18172
  • [4] Negative regulation of FOXC1 activity by the p44/p42 MAP kinase pathway.
    Mirzayans, FM
    Berry, FB
    Saleem, RA
    Walter, MA
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 339 - 339
  • [5] p38 mitogen-activated protein (MAP) kinase but not p44/p42 MAP kinase is involved in prostaglandin E1-induced vascular endothelial growth factor synthesis in osteoblasts
    Tokuda, H
    Kozawa, O
    Miwa, M
    Uematsu, T
    JOURNAL OF ENDOCRINOLOGY, 2001, 170 (03) : 629 - 638
  • [6] Resveratrol suppresses insulin-like growth factor I-induced osteoblast migration: attenuation of the p44/p42 MAP kinase pathway
    Hioki, Tomoyuki
    Kawabata, Tetsu
    Sakai, Go
    Fujita, Kazuhiko
    Kuroyanagi, Gen
    Matsushima-Nishiwaki, Rie
    Kim, Woo
    Otsuka, Takanobu
    Iida, Hiroki
    Tokuda, Haruhiko
    Kozawa, Osamu
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2020, 84 (12) : 2428 - 2439
  • [7] Cardioprotective effects of transforming growth factor-β1 during early reoxygenation or reperfusion are mediated by p42/p44 MAPK
    Baxter, GF
    Mocanu, MM
    Brar, BK
    Latchman, DS
    Yellon, DM
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2001, 38 (06) : 930 - 939
  • [8] IFN-γ gene expression in epithelial trophectoderm cells is linked to downregulation of the p44/p42 MAP kinase pathway
    Marcelo, P
    Lefèvre, F
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2004, 24 (01): : 29 - 36
  • [9] Adhesion-dependency of serum-induced p42/p44 MAP kinase activation is released by retroviral oncogenes
    Inoue, H
    Yamashita, A
    Hakura, A
    VIROLOGY, 1996, 225 (01) : 223 - 226
  • [10] Transforming growth factor-β stimulates articular chondrocyte cell growth through p44/42 MAP kinase (ERK) activation
    Yonekura, A
    Osaki, M
    Hirota, Y
    Tsukazaki, T
    Miyazaki, Y
    Matsumoto, T
    Ohtsuru, A
    Namba, H
    Shindo, H
    Yamashita, S
    ENDOCRINE JOURNAL, 1999, 46 (04) : 545 - 553